• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Groundbreakers: Marcus Maria

Microdose by Microdose
September 16, 2021
in Psychedelic Groundbreakers
Reading Time: 2 mins read
A A
Psychedelic Groundbreakers: Marcus Maria

This week’s Psychedelic Groundbreaker is Marcus Maria. Marcus Maria is a house of psychedelic brands. They are building psychedelic brands that address the quality, accessibility, and convenience of psychedelic mushrooms to normalize their place in society.

What’s this article series about? Psychedelic Groundbreakers is a get-to-know-you-style blog series highlighting prominent and groundbreaking companies in the psychedelics industry.

What’s your company vision?

Marcus Maria is a house of psychedelic brands.
We are building psychedelic brands that address the quality, accessibility, and convenience of psychedelic mushrooms to normalize their place in society.

Why was your company started?

Our founder has been cultivating gourmet, medicinal, and psychedelic mushrooms for the past 8 years and endeavoring to make psychedelic mushrooms more accessible to the average person. In 2019, the unexpected death of his mother, spurred him to create our first brand, jennyjill which is dedicated to her life’s quest of exploring herbs, tinctures and alternative medicines to heal herself and those around her.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

What’s been the biggest challenge so far?

Educating the public about the dosage, effects, safety, etc. around the use of psychedelic mushrooms is a big hurdle that the entire industry faces.

Continue on your trip...

After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma?

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric Biosciences: Poised to Outshine Traditional Psychedelic Targets

Psychedelic Groundbreakers: Marcus Maria

What excites you most?

It’s a toss-up between the industry’s potential and the feedback we get from our members. Macroscopically, the widespread acceptance of entheogenic medicines sweeping the nation is something I couldn’t even dare to dream of 8 years ago. On a micro-level, the positive feedback we hear when someone has introduced our product into their routine keeps us going. We’ve heard so many stories that someone has replaced their SSRIs or Adderall with Matcha Micro and it has changed their lives for the better. That’s huge!

What is your biggest lesson learned when raising capital?

Purchase Lasix

Grind. It’s a long path, don’t get discouraged.

Did you notice any type of investor differences while raising money?

They’re all different. They all have different questions and ways of seeing. You gotta take them as they come and hope they’re able to see what you’re trying to accomplish.

Describe your business model in 10 words or less

Entheogenic mushroom products that affect mental, spiritual, and physical well-being.

What tips would you give founders entering fundraising?

It can be a long, slow burn. Take every opportunity that comes your way to pitch your company, but commit to those who align with your vision and passion.

 

We’d like to thank Marcus Maria for being a part of the Psychedelic Groundbreaker series. Stay tuned for more profiles on leaders in the psychedelic industry.

Would you like to participate in this series? Fill out this form and we’ll follow up with a review of your application.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Marcus Maria
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post

Psychedelic Retreat Group Kaivalya Kollectiv Welcomes The Conscious Fund onto Advisory Board

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.